Exchange / Market
AB Science is a pharmaceutical company specializing in the discovery, development and commercialization of novel targeted therapies named protein kinase inhibitors. Our target diseases are cancers, inflammatory diseases, with high unmet medical need in both human and veterinary medicine. AB Science was created in 2001. The company is headquartered in Paris and has a subsidiary in the USA.
Initial Public offering